血脂管理作为心血管疾病防控的重要环节，既是备受瞩目的公共卫生课题，更是紧贴民生的健康焦 点。首都医科大学附属北京安贞医院心脏内科中心主任马长生近日就如何对血脂进行科学管理分享观 点。他建议运用现代技术手段创新血脂检测，并鼓励跨领域、多策略协作，联合应对血脂管理难题，推 动心血管疾病防控更加精准化与普惠化。 聚焦源头防控 智慧加持助力血脂管理 《健康中国行动（2019—2030年）》将心脑血管疾病防治列为专项行动之一，并对降低心脑血管疾 病死亡率提出要求。血脂作为影响着心脑血管健康的重要因素，对其开展干预措施有助于预防心脑血管 疾病的发生。 在马长生看来，做好血脂管理是实现心血管疾病防控的"必答题"。"心脏健康涵盖血压、血脂、血 糖三大指标，以及体重、吸烟、运动、饮食、睡眠等生活方式因素。如果血脂控制不佳，易引发心肌梗 死、脑卒中等心脑血管疾病"。 "从临床实践来看，我国的血脂异常患者不少，但知晓率、治疗率、控制率较低，这意味着大量患 者正处于'无症状但高风险'的状态，很多人直到发病，才发现自己存在血脂超标的问题。"马长生建 议，要推动血脂管理从专业的医学指导转为大众自觉的健康行动，帮助更多人通过科学防控远离心 ...

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of 5% to 15% over the next 6 to 12 months [3][9]. Core Insights - The company achieved stable revenue growth in H1 2025, with total revenue of 1.448 billion RMB, a year-on-year increase of 2.68%, and a net profit attributable to shareholders of 321 million RMB, up 3.66% year-on-year [1]. - The orthodontics segment showed strong performance, generating 229 million RMB in revenue, reflecting a year-on-year growth of 7.75%, continuing the recovery trend from Q1 [1][2]. - The company's operational model, combining regional hospitals and branch hospitals, has shown significant expansion, with 89 medical institutions and over 4,452 medical professionals [2]. - The integration of AI technology into clinical diagnosis and operational management has enhanced efficiency, positioning the company competitively in the market [2]. Summary by Sections Performance Review - In H1 2025, the company reported revenue of 1.448 billion RMB, with a net profit of 321 million RMB, and a non-recurring net profit of 317 million RMB [1]. - In Q2 2025, revenue was 703 million RMB, with a net profit of 137 million RMB, showing a slight year-on-year increase of 0.24% [1]. Business Analysis - The orthodontics business is recovering well, while the implant business remained stable with revenue of 255 million RMB, showing a minimal year-on-year change of 0.02% [1]. - Pediatric business revenue decreased by 1.48% to 236 million RMB [1]. Growth Strategy - The company operates 89 medical institutions and employs 4,452 medical professionals, with a medical space exceeding 260,000 square meters [2]. - The "medical + technology" strategy is being deepened, leveraging AI to improve operational efficiency and clinical decision-making [2]. Profit Forecast and Valuation - The company is projected to achieve net profits of 537 million RMB, 574 million RMB, and 610 million RMB for the years 2025, 2026, and 2027, respectively, with expected growth rates of 7%, 6.82%, and 6.35% [3][7]. - The estimated EPS for the same years is 1.20, 1.28, and 1.36 RMB, with corresponding PE ratios of 39, 36, and 34 times [3].

Core Insights - The article emphasizes the importance of integrating clinical, capital, channel, and regulatory aspects to drive high-quality development in the medical technology sector, particularly focusing on Chinese innovation in the global context [1]. Group 1: Medical Ecosystem and Innovation - The Shanghai Jiao Tong University School of Medicine is highlighted as a key player in fostering a valuable medical and health ecosystem, with 13 affiliated hospitals and 21 academicians providing strong academic support and clinical resources for entrepreneurs [9]. - The establishment of the first incubation fund by the Medical Future Alumni Association aims to lead alumni in early investments in medical technology, facilitating earlier market entry [9]. - The article discusses the unique "Value Engine Methodology" that promotes collaboration between academia and industry, enhancing strategic thinking, innovation capabilities, and leadership skills among entrepreneurs [9][10]. Group 2: Educational Programs and Curriculum - The curriculum is designed to address trends, challenges, and innovations in the medical industry, helping participants understand the development trajectory and strategic layout of the sector [11]. - The program emphasizes the cultivation of entrepreneurial thinking, enabling participants to formulate growth strategies and make informed decisions in uncertain market conditions [12]. - Various modules cover topics such as strategic customization, value discovery, and innovative thinking, aimed at equipping participants with the necessary skills for future challenges in the medical field [16]. Group 3: Industry Trends and Future Directions - The article identifies key trends in the medical industry, including the aging economy, consumer healthcare, and the integration of technology in healthcare services [17][19]. - It discusses the importance of understanding the silver economy's value chain, including sectors like elderly care, rehabilitation, and entertainment, as well as the emerging business models in consumer healthcare [19]. - The integration of new technologies such as artificial intelligence, big data, and wearable devices is highlighted as a significant trend shaping the future of the medical industry [19].

Core Insights - The article emphasizes the importance of integrating clinical, capital, channel, and regulatory aspects to drive high-quality development in the medical technology sector, particularly focusing on Chinese innovation in the global context [1]. Group 1: Medical Ecosystem and Innovation - The Shanghai Jiao Tong University School of Medicine is highlighted as a key player in fostering a valuable medical and health ecosystem, with 13 affiliated hospitals and 21 academicians providing strong academic support and clinical resources for entrepreneurs [9]. - The establishment of the first incubation fund by the Medical Future Alumni Association aims to lead alumni in incubating medical technology ventures, facilitating early investments in the sector [9][10]. - The curriculum is designed to help participants understand the trends, challenges, and innovations within the medical industry, enhancing their strategic insights and operational capabilities [11]. Group 2: Entrepreneurial Mindset and Strategic Development - The program focuses on cultivating an entrepreneurial mindset, enabling participants to navigate complex environments, identify opportunities, and develop growth strategies [12]. - The "Value Engine Methodology" is introduced as a framework for personal and organizational capability enhancement, emphasizing the importance of collaboration between academia and industry [13]. - The curriculum includes modules on strategic diagnosis, execution paths, and commercial model design, aimed at equipping participants with the skills to innovate and grow within the medical sector [16]. Group 3: Industry Trends and Future Directions - The article discusses the emerging trends in the medical industry, including the silver economy, consumer healthcare, and the integration of technology in healthcare applications [17][19]. - It highlights the significance of understanding the evolving landscape of consumer healthcare, including sectors like aesthetic medicine, dental care, and preventive health check-ups [19]. - The program also addresses the application of new technologies such as artificial intelligence, big data, and telemedicine in transforming healthcare delivery [19].

Core Viewpoint - The 2025 Alumni Conference of Shanghai Jiao Tong University School of Medicine aims to create a platform for emotional connection, resource sharing, and opportunity exchange under the theme "Co-construct, Share, and Co-future" [2]. Agenda Summary - The conference will feature a series of speeches and discussions on various topics related to medical policies, industry opportunities, and advancements in healthcare [3][4]. - Keynote speakers include prominent figures such as Xu Shuqiang, Gu Yan, and Ren Yongqiang, who will address topics like medical policies, obesity treatment, and anti-aging cell therapies [3][4]. - A roundtable discussion will focus on the challenges and strategies for medical companies expanding internationally, featuring industry leaders and experts [4]. Educational Program - The Medical and Health Future Leading Talents program offers a comprehensive curriculum designed to enhance entrepreneurial thinking and strategic capabilities in the healthcare sector [5][6]. - The program emphasizes collaboration between academia and industry, aiming to develop leaders who can navigate complex challenges in the medical field [8][11]. - Participants will engage in workshops and discussions on topics such as innovation in medical products, investment strategies, and the integration of new technologies in healthcare [17][12]. Networking Opportunities - The conference will facilitate networking among alumni, industry leaders, and academic experts, providing a platform for resource matching and innovative collaboration [9][21]. - Attendees will have the chance to visit leading medical institutions and companies, enhancing their understanding of the healthcare ecosystem [21][20]. Alumni Engagement - The alumni association aims to foster a vibrant and innovative community, organizing events that connect scientists and entrepreneurs for knowledge exchange and collaboration [18][19]. - The program includes international study tours to renowned medical institutions, further enriching the learning experience for participants [22][21].

字MedTech 全球最新医疗科技动态 ： 思宇MedTech | MedRobot | 心未来 | 眼未来 | 骨未来 | 探美医界 | 医影像 寻求报道，请联系Alice：suribot21 投稿/订制报告，请联系主编： qingzhao2017 SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE 第十期 MEDICAL AND HEALTH FUTURE LEADING TALENTS 300位 多目 8 TE 医健同侨印证启迪 课程送代积淀 思维破茧和能力跃迁 上海文进, 66 这里有独具价值的 医健生态圈层 B 变局时代企业家思维破茧 全面打通产学研用 解锁医疗产业未来 成就卓越领军人才 我们面临的问题无比复杂, 您需要站在更高的平台, 洞祭趋势,明确方向,做出取舍, 分合行动,聚拢资源, 成为医疗产业未来的合格舵手! 00 0 0 00 /0 N7/2 | THE 课程价值 上海交通大学医学院拥有: 日 13家附属医院 R 21位院士 转化医学国家重大科技基础设施(上海) 为企业家提供了强大的学术支持、创新平台 和临床转化资源 独创价值引擎方法论 以" ...

号MedTech 全球最新医疗科技动态 车： 思宇MedTech | MedRobot | 心未来 | 眼未来 | 骨未来 | 探美医界 | 医影像 寻求报道，请联系Alice：suribot21 投稿/订制报告，请联系主编： qingzhao2017 学院 SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE 第十期 MEDICAL AND HEALTH FUTURE LEADING TALENTS 多重 8年 300位 医健同侪印证启迪 课程送代积淀 思维破茧和能力跃迁 66 这里有独具价值的 医健生态圈层 THERE IS A VALUABLE MEDICAL AND HEALTH ECOSYSTEM HERE 变局时代企业家思维破茧 全面打通产学研用 解锁医疗产业未来 成就卓越领军人才 我们面临的问题无比复杂, 您需要站在更高的平台, 洞察趋势,明确方向,做出取舍, 统合行动,聚拢资源, 成为医疗产业未来的合格舵手! NOLILIA VALUE 课程价值 上海交通大学医学院拥有: 日 | 13家附属医院 R 21位院士 201 t+ 转化医学国家重大科技基础 ...

学院 SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE 第十期 MEDICAL AND HEALTH FUTURE LEADING TALENTS 多重 8年 300位 医健同侪印证启迪 课程送代积淀 思维破茧和能力跃迁 号MedTech 全球最新医疗科技动态 车： 思宇MedTech | MedRobot | 心未来 | 眼未来 | 骨未来 | 探美医界 | 医影像 寻求报道，请联系Alice：suribot21 投稿/订制报告，请联系主编： qingzhao2017 66 这里有独具价值的 医健生态圈层 THERE IS A VALUABLE MEDICAL AND HEALTH ECOSYSTEM HERE 变局时代企业家思维破茧 全面打通产学研用 解锁医疗产业未来 成就卓越领军人才 我们面临的问题无比复杂, 您需要站在更高的平台, 洞察趋势,明确方向,做出取舍, 统合行动,聚拢资源, 成为医疗产业未来的合格舵手! NOLILIA VALUE 课程价值 上海交通大学医学院拥有: 日 | 13家附属医院 R 21位院士 201 t+ 转化医学国家重大科技基础 ...